Fuling (Poria cocos) is a traditional Chinese medicinal herb with a sweet, bland taste and neutral nature, which is attributed to the heart, lung, spleen, and kidney meridians. It exerts the effects of inducing diuresis to eliminate dampness, invigorating the spleen and tranquilizing the mind, and is mainly indicated for the treatment of symptoms and diseases including edema with oliguria, phlegm retention accompanied by vertigo and palpitations, poor appetite caused by spleen deficiency, loose stools and diarrhea, mental restlessness, and palpitations with insomnia. Studies have shown that the active components of P. cocos mainly include polysaccharides, triterpenes, sterols, and so on. It exhibits various pharmacological activities, such as diuretic, immunomodulatory, antitumor, lipid-regulating, anti-inflammatory, antioxidant, and other effects. By systematically searching relevant literature at home and abroad, this study comprehensively reviews the chemical components and pharmacological effects of P. cocos, and further explores its potential mechanisms of action, aiming to provide new ideas and scientific basis for the modern research and clinical development of P. cocos.
FENG Xue, GUO Xiaosong, XIE Fei, LIU Yan, WEI Ning, GONG Wenxia.
Research progress on chemical components and pharmacological effects of Poria cocos[J].
Chinese Traditional and Herbal Drugs,
2026
, 57
(5)
: 1947
-1957
.
DOI: 10.7501/j.issn.0253-2670.2026.05.030
基金
收起
漯河市中医院2024年度科技创新项目 (KJCXZYY202409)
参考文献
收起
文献
收起
参考文献引证文献
排序方式：
中国药典[S]. 一部. 2025: 259-260. 邓桃妹, 彭代银, 俞年军, 等. 茯苓化学成分和药理作用研究进展及质量标志物的预测分析[J]. 中草药, 2020, 51(10): 2703-2717. 厉晓, 龚婕, 丁婵, 等. 茯苓多糖的结构、活性及其构效关系研究进展[J]. 中草药, 2025, 56(1): 305-317. 赵佳琛, 王艺涵, 金艳, 等. 经典名方中茯苓的本草考证[J]. 中国实验方剂学杂志, 2022, 28(10): 327-336. 郭阳. 真武汤合桂枝茯苓丸加味治疗慢性心力衰竭(阳虚血瘀型)的临床观察及对Hcy、Cys-C水平影响[D]. 重庆: 重庆医科大学, 2025. Zhang Y, Zhou H P, Yu J, et al. Poria cocos in traditional Chinese medicine: multifaceted insights[J]. Acupunct Herb Med, 2025, 5(4): 498-527. Tsai Y C, Tsai C C, Lin Y H, et al. Chinese herbal medicine in the treatment of chronic kidney disease: A narrative review of mechanisms and therapeutic potential[J]. Iran J Pharm Res, 2025, 24(1): e165904. Zhang Y Z, Du L, Liu B N, et al. Study on the progress of application of Qingxin Lianzi Drink in paediatric nephrotic syndrome[J]. Altern Ther Health Med, 2023, 29(8): 882-891. Ma D C, Yang H, Zhao M Y, et al. Multi-target regulatory mechanisms and clinical assessment of natural products for insomnia: A review[J]. Front Pharmacol, 2026, 17: 1681709. Liao Y S, Cai W W, Yang R L, et al. Application frequency research on insomnia correlated treatment of Chinese herbs[J]. Biomed J Sci Tech Res, 2018, 10(5): 1-7. 邵璐, 曹峰, 孟鑫, 等. 茯苓甘草汤对功能性消化不良模型大鼠胃组织及海马组织中AQP3、AQP4蛋白表达的影响[J]. 实用中医药杂志, 2023, 39(6): 1054-1057. Tibenda J J, Gu Q, Duan S, et al. The mechanistic role of Poria cocos in cancer treatment: Antitumor activity and adjuvant potential in chemotherapy[J]. Fitoterapia, 2025, 188: 107016. Peng X Y, Jia C C, Chi H, et al. Efficacy and pharmacological mechanism of Poria cocos-based formulas combined with chemotherapy for ovarian cancer: A integrated systems pharmacology study[J]. Front Pharmacol, 2022, 13: 788810. Lee H K, Cha H J. Poria cocos Wolf extracts represses pigmentation in vitro and in vivo[J]. Cell Mol Biol, 2018, 64(5): 80-84. Lee E J, Bae S Y, Son R H, et al. The inhibitory effects of Poria cocos Bark extract on melanogenesis[J]. J Soc Cosme Sci Korea, 2009, 35(3): 243-250. 高满军, 赵宝清, 莫启贵, 等. 茯苓的化学成分及其调节糖脂代谢的研究进展[J]. 湖北科技学院学报: 医学版, 2023, 37(3): 272-276. Yue S, Feng X, Cai Y S, et al. Regulation of tumor apoptosis of poriae cutis-derived lanostane triterpenes by Akt/PI3K and MAPK signaling pathways in vitro[J]. Nutrients, 2023, 15(20): 4360. Zhou X Y, Wang J C, Zhou S F. Poria cocos polysaccharides improve alcoholic liver disease by interfering with ferroptosis through Nrf2 regulation[J]. Aging, 2024, 16(7): 6147-6162. 张年, 李兆星, 李娟, 等. 茯苓的化学成分与生物活性研究进展[J]. 世界科学技术—中医药现代化, 2019, 21(2): 220-233. Nie A Z, Chao Y H, Zhang X C, et al. Phytochemistry and pharmacological activities of Wolfiporia cocos (F. A. Wolf) Ryvarden & Gilb.[J]. Front pharmacol, 2020, 11: 505249-505249. 左军, 祁天立, 胡晓阳. 茯苓化学成分及现代药理研究进展[J]. 中医药学报, 2023, 51(1): 110-114. Qian Q, Zhou N, Qi P C, et al. A UHPLC-QTOF-MS/MS method for the simultaneous determination of eight triterpene compounds from Poria cocos (Schw.) Wolf extract in rat plasma: Application to a comparative pharmacokinetic study[J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2018, 1102: 34-44. Lu J, Tian J, Zhou L, et al. Phytochemistry and biological activities of Poria[J]. J Chem, 2021, 2021(1): 6659775. 纪明池, 姜思亮, 刘雪晴, 等. 茯苓多糖的化学结构及药理作用研究进展[J]. 中医药学报, 2025, 53(12): 122-129. 丁琼, 张俐娜, 张志强. 茯苓菌丝体多糖的分离及结构分析[J]. 高分子学报, 2000(2): 224-227. 刘永飞, 任艳玲, 王涛, 等. 茯苓中麦角-7,22E-二烯-3β-醇的靶点蛋白PRGR的结构分析与功能预测[J]. 食品与生物技术学报, 2025, 44(10): 163-172. 席志军, 张艳玲. 茯苓中重金属和微量元素含量的测定[J]. 现代医学与健康研究电子杂志, 2022, 6(23): 18-20. 胡朝暾, 唐霞, 肖震, 等. 茯苓发酵液中蛋白质的电泳分离与质谱分析[J]. 中草药, 2016, 47(13): 2269-2276. 陈蓉, 张超, 顾倩, 等. 柱前衍生-HPLC法同时测定不同产地茯苓中18种氨基酸含量[J]. 药物分析杂志, 2017, 37(2): 297-303 Wu Z L, Ren H, Lai W Y, et al. Sclederma of Poria cocos exerts its diuretic effect via suppression of renal aquaporin-2 expression in rats with chronic heart failure[J]. J Ethnopharmacol, 2014, 155(1): 563-571. 邓刚民, 许津. 茯苓素: 一种潜在的醛固酮拮抗剂[J]. 中国抗生素杂志, 1992, 17(1): 34-37. 田婷, 陈华, 殷璐, 等. 茯苓和茯苓皮水和乙醇提取物的利尿作用及其活性成分的分离鉴定[J]. 中国药理学与毒理学杂志, 2014, 28(1): 57-62. 周宏超, 高立云, 范光丽, 等. 茯苓酸对SLT-Ⅱe诱导大鼠肠黏膜微血管内皮细胞分泌细胞因子的影响[J]. 中国兽医科学, 2008, 38(10): 884-888. 杨婷, 徐旭, 窦德强. 茯苓对上焦水饮内停大鼠的利水作用研究[J]. 辽宁中医杂志, 2017, 44(5): 1096-1099. 江薇. 茯苓酸通过激活多聚腺苷二磷酸核糖聚合酶诱导人乳腺癌细胞MDA-MB-231凋亡[J]. 中草药, 2016, 47(21): 3861-3865. Ling H, Zhang Y C, Ng K Y, et al. Pachymic acid impairs breast cancer cell invasion by suppressing nuclear factor-κB-dependent matrix metalloproteinase-9 expression[J]. Breast Cancer Res Treat, 2011, 126(3): 609-620. 王晓菲, 刘春琰, 窦德强. 中药茯苓抗肿瘤有效组分研究[J]. 辽宁中医杂志, 2014, 41(6): 1240-1244. 石明亮, 王晓磊, 申洋, 等. 茯苓酸调节Hippo信号通路对二乙基亚硝胺诱导的肝癌大鼠的治疗作用研究[J]. 天津中医药, 2024, 41(1): 99-105. 李桂芹, 吴晓锋, 唐万侠. 茯苓化学成分及生理活性研究[J]. 齐齐哈尔大学学报: 自然科学版, 2015, 31(4): 50-54. Jiang F, Zhu T M, Yang C F, et al. Pachymic acid inhibits growth and metastatic potential in liver cancer HepG2 and Huh7 cells[J]. Biol Pharm Bull, 2023, 46(1): 35-41. Wang J R, Li Y Y, Liu D N. Cloning and characterization of farnesyl diphosphate synthase gene involved in triterpenoids biosynthesis from Poria cocos[J]. Int J Mol Sci, 2014, 15(12): 22188-22202. 张树瑛, 石齐, 殷晓聆, 等. 茯苓酸调控PI3K/Akt/ mTOR通路介导葡萄糖代谢促进结直肠癌细胞凋亡的机制研究[J]. 中华中医药学刊, 2024, 42(9): 65-69. Mizushina Y, Akihisa T, Ukiya M, et al. A novel DNA topoisomerase inhibitor: Dehydroebriconic acid, one of the lanostane-type triterpene acids from Poria cocos[J]. Cancer Sci, 2004, 95(4): 354-360. Akihisa T, Uchiyama E, Kikuchi T, et al. Anti-tumor-promoting effects of 25-methoxyporicoic acid a and other triterpene acids from Poria cocos[J]. J Nat Prod, 2009, 72(10): 1786-1792. Akihisa T, Nakamura Y, Tokuda H, et al. Triterpene acids from Poria cocos and their anti-tumor-promoting effects[J]. J Nat Prod, 2007, 70(6): 948-953. 唐恩红, 蔡旺. 茯苓多糖对人宫颈癌HeLa细胞增殖、迁移、促凋亡的影响及其机制[J]. 肿瘤防治研究, 2019, 46(8): 707-713. 李琳琳. 茯苓多糖联合顺铂对Lewis肺腺癌移植瘤的抑瘤作用及VEGF、p-STAT3、CD31表达的影响[D]. 张家口: 河北北方学院, 2021. 魏科, 陈勇超, 周家豪, 等. 茯苓多糖辅助抗肺癌及免疫调节作用研究[J]. 中华中医药杂志, 2020, 35(10): 4937-4940. 温欣. 茯苓多糖口服液减少含铂化疗不良反应有效性临床研究[D]. 乌鲁木齐: 新疆医科大学, 2020. 张志军, 冯霞, 蒋娟, 等. 茯苓多糖对小鼠血清IgA、IgG和IgM生物合成水平的影响[J]. 中国免疫学杂志, 2013, 29(11): 1213-1215. Lv Y Z, Yang Y J, Chen Y, et al. Structural characterization and immunomodulatory activity of a water-soluble polysaccharide from Poria cocos[J]. Int J Biol Macromol, 2024, 261: 129878. Tian H, Liu Z J, Pu Y W, et al. Immunomodulatory effects exerted by Poria cocos polysaccharides via TLR4/TRAF6/ NF-κB signaling in vitro and in vivo[J]. Biomed Pharmacother, 2019, 112: 108709. 肖颖, 吴梦琪, 张文清, 等. 茯苓多糖HPLC指纹图谱与免疫活性的相关分析[J]. 华东理工大学学报: 自然科学版, 2020, 46(5): 672-679. Wu Y J, Li S, Li H X, et al. Effect of a polysaccharide from Poria cocos on humoral response in mice immunized by H1N1 influenza and HBsAg vaccines[J]. Int J Biol Macromol, 2016, 91: 248-257. Chao C L, Huang H W, Su M H, et al. The lanostanetriterpenoids in Poria cocos play beneficial roles inimmunoregulatory activity[J]. Life, 2021, 11(2): 111. 倪付勇, 谢雪, 温建辉, 等. 茯苓非多糖类化学成分的抗补体活性[J]. 中草药, 2019, 50(11): 2529-2533. 李春雨, 刘宏宇, 张国伟, 等. 茯苓酸抗大鼠心脏移植急性排斥反应的实验研究[J]. 中国胸心血管外科临床杂志, 2010, 17(2): 136-139. 汪电雷, 陈卫东, 徐先祥. 茯苓总三萜的抗炎作用研究[J]. 安徽医药, 2009, 13(9): 1021-1023. Lee S R, Lee S, Moon E, et al. Bioactivity-guided isolation of anti-inflammatory triterpenoids from the Sclerotia of Poria cocos using LPS-stimulated RAW264.7 cells[J]. Bioorg Chem, 2017, 70: 94-99. Li F F, Yuan Y, Liu Y, et al. Pachymic acid protects H9c2 cardiomyocytes from lipopolysaccharide-induced inflammation and apoptosis by inhibiting the extracellular signal-regulated kinase 1/2 and p38 pathways[J]. Mol Med Rep, 2015, 12(2): 2807-2813. Cai T G, Cai Y. Triterpenes from the fungus Poria cocos and their inhibitory activity on nitric oxide production in mouse macrophages via blockade of activating protein-1 pathway[J]. Chem Biodivers, 2011, 8(11): 2135-2143. 赵强强. 茯苓多糖的抗炎效果及其对小鼠免疫功能影响的初步研究[D]. 武汉: 华中科技大学, 2010. Liu J S, Yu J T, Peng X C. Poria cocos polysaccharides alleviates chronic nonbacterial prostatitis by preventing oxidative stress, regulating hormone production, modifying gut microbiota, and remodeling the DNA methylome[J]. J Agric Food Chem, 2020, 68(45): 12661-12670. 石振国, 苏锦, 任永乐, 等. 茯苓多糖对急性胰腺炎大鼠肠道屏障功能损伤和炎性反应的作用[J]. 海南医学, 2017, 28(3): 356-359. 李燕凌, 张志旭, 胡令. 茯苓多糖抗氧化性研究[J]. 天然产物研究与开发, 2012, 24(8): 1126-1128. 汤凯, 周际松, 叶帆宇, 等. 硫酯化碱溶性茯苓多糖的抗氧化性分析[J]. 中国食品添加剂, 2020, 31(7): 21-26. 姜悦航, 张越, 王妍妍, 等. 茯苓多糖提取物调控CYP2E1及NF-κB炎症通路改善小鼠酒精性肝病[J]. 中国中药杂志, 2022, 47(1): 134-140. 刘晓英, 马诗经, 韩萍, 等. 不同分子量茯苓多糖抑制酪氨酸酶活性及抗炎功效的研究[J]. 中国食用菌, 2021, 40(9): 47-53. 黄聪亮, 郑佳俐, 李凤林, 等. 茯苓多糖对2型糖尿病小鼠肾组织抗氧化能力及Bax、Bcl-2蛋白表达影响[J]. 食品与生物技术学报, 2016, 35(1): 82-88. Lee S G, Kim M M. Pachymic acid promotes induction of autophagy related to IGF-1 signaling pathway in WI-38 cells[J]. Phytomedicine, 2017, 36: 82-87. 梁亦龙, 曾垂省, 王允, 等. 茯苓多糖的抗氧化作用[J]. 江苏农业科学, 2012, 40(7): 288-289. Cai H, Cheng Y J, Zhu Q N, et al. Identification of triterpene acids in Poria cocos extract as bile acid uptake transporter inhibitors[J]. Drug Metab Dispos, 2021, 49(5): 353-360. Sun S S, Wang K, Ma K, et al. An insoluble polysaccharide from the Sclerotium of Poria cocos improves hyperglycemia, hyperlipidemia and hepatic steatosis in ob/ob mice via modulation of gut microbiota[J]. Chin J Nat Med, 2019, 17(1): 3-14. Huang Y C, Chang W L, Huang S F, et al. Pachymic acid stimulates glucose uptake through enhanced GLUT4 expression and translocation[J]. Eur J Pharmacol, 2010, 648(1/2/3): 39-49. 毛跟年, 张诗韵, 付超, 等. 茯苓皮总三萜的降血脂活性研究[J]. 陕西科技大学学报: 自然科学版, 2015, 33(3): 130-134. 谢骏, 王媛媛, 李聚鑫, 等. 茯苓多糖调控Rho-ROCK信号通路对心肌缺血再灌注损伤大鼠心肌细胞凋亡的影响和机制研究[J]. 中国中药杂志, 2023, 48(23): 6434-6441. 王琼, 赵明君, 董静, 等. 茯苓多糖通过NF-κB通路减轻心肌梗死大鼠组织损伤[J]. 重庆医学, 2022, 51(19): 3247-3252. 冯莉莉, 曹慧, 李贺. 茯苓酸通过调节JAK2/STAT3/ SOCS3信号通路减轻急性心肌梗死大鼠的心肌纤维化[J]. 标记免疫分析与临床, 2023, 30(9): 1539-1545. 桑晶, 李璐, 姜洁, 等. 茯苓酸对大鼠心肌缺血再灌注损伤的影响机制研究[J]. 局解手术学杂志, 2023, 32(10): 859-864. 王飞飞, 陈伯艳, 李琼. 茯苓酸通过调节Nrf2/ SLC7A11/GPX4信号通路抑制氧糖剥夺/复氧诱导的心肌细胞铁死亡[J]. 中西医结合心脑血管病杂志, 2024, 22(2): 267-273. Wu K, Fan J L, Huang X Y, et al. Hepatoprotective effects exerted by Poria cocos polysaccharides against acetaminophen-induced liver injury in mice[J]. Int J Biol Macromol, 2018, 114: 137-142. 程玥. 茯苓多糖分离纯化、结构表征、保肝活性及其对CYP2E1酶影响研究[D]. 合肥: 安徽中医药大学, 2021. Wu K, Qin J R, Liu M Z, et al. Bioinformatics approach and experimental validation reveal the hepatoprotective effect of pachyman against acetaminophen-associated liver injury[J]. Aging, 2023, 15(17): 8800-8811.
PDF下载
全屏
27
9
关闭全屏
北京市海淀区学院南路86号
010-62199257（仅加盟咨询）
qkjq@cast.org.cn
